Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma

Identifieur interne : 00B416 ( Main/Exploration ); précédent : 00B415; suivant : 00B417

Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma

Auteurs : D. Timothy Bishop [Australie] ; Florence Demenais [Australie] ; Alisa M. Goldstein [Australie] ; Wilma Bergman [Australie] ; Julia Newton Bishop [Australie] ; Brigitte Bressac-De Paillerets [Australie] ; Agne S Chompret [Australie] ; Paola Ghiorzo [Australie] ; Nelleke Gruis [Australie] ; Johan Hansson [Australie] ; Mark Harland [Australie] ; Nicholas Hayward [Australie] ; Elizabeth A. Holland [Australie] ; Graham J. Mann [Australie] ; Michela Mantelli [Australie] ; Derek Nancarrow [Australie] ; Anton Platz [Australie] ; Margaret A. Tucker [Australie]

Source :

RBID : ISTEX:2DFFC5703ECEE7285C33FFD09BA864A9429998AF

Descripteurs français

English descriptors

Abstract

Background: Germline mutations in the CDKN2A gene, which encodes two proteins (p16INK4A and p14ARF), are the most common cause of inherited susceptibility to melanoma. We examined the penetrance of such mutations using data from eight groups from Europe, Australia and the United States that are part of The Melanoma Genetics Consortium. Methods: We analyzed 80 families with documented CDKN2A mutations and multiple cases of cutaneous melanoma. We modeled penetrance for melanoma using a logistic regression model incorporating survival analysis. Hypothesis testing was based on likelihood ratio tests. Covariates included gender, alterations in p14ARF protein, and population melanoma incidence rates. All statistical tests were two-sided. Results: The 80 analyzed families contained 402 melanoma patients, 320 of whom were tested for mutations and 291 were mutation carriers. We also tested 713 unaffected family members for mutations and 194 were carriers. Overall, CDKN2A mutation penetrance was estimated to be 0.30 (95% confidence interval (CI) = 0.12 to 0.62) by age 50 years and 0.67 (95% CI = 0.31 to 0.96) by age 80 years. Penetrance was not statistically significantly modified by gender or by whether the CDKN2A mutation altered p14ARF protein. However, there was a statistically significant effect of residing in a location with a high population incidence rate of melanoma (P = .003). By age 50 years CDKN2A mutation penetrance reached 0.13 in Europe, 0.50 in the United States, and 0.32 in Australia; by age 80 years it was 0.58 in Europe, 0.76 in the United States, and 0.91 in Australia. Conclusions: This study, which gives the most informed estimates of CDKN2A mutation penetrance available, indicates that the penetrance varies with melanoma population incidence rates. Thus, the same factors that affect population incidence of melanoma may also mediate CDKN2A penetrance.

Url:
DOI: 10.1093/jnci/94.12.894


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma</title>
<author>
<name sortKey="Bishop, D Timothy" sort="Bishop, D Timothy" uniqKey="Bishop D" first="D. Timothy" last="Bishop">D. Timothy Bishop</name>
</author>
<author>
<name sortKey="Demenais, Florence" sort="Demenais, Florence" uniqKey="Demenais F" first="Florence" last="Demenais">Florence Demenais</name>
</author>
<author>
<name sortKey="Goldstein, Alisa M" sort="Goldstein, Alisa M" uniqKey="Goldstein A" first="Alisa M." last="Goldstein">Alisa M. Goldstein</name>
</author>
<author>
<name sortKey="Bergman, Wilma" sort="Bergman, Wilma" uniqKey="Bergman W" first="Wilma" last="Bergman">Wilma Bergman</name>
</author>
<author>
<name sortKey="Bishop, Julia Newton" sort="Bishop, Julia Newton" uniqKey="Bishop J" first="Julia Newton" last="Bishop">Julia Newton Bishop</name>
</author>
<author>
<name sortKey="Paillerets, Brigitte Bressac De" sort="Paillerets, Brigitte Bressac De" uniqKey="Paillerets B" first="Brigitte Bressac-De" last="Paillerets">Brigitte Bressac-De Paillerets</name>
</author>
<author>
<name sortKey="Chompret, Agne S" sort="Chompret, Agne S" uniqKey="Chompret A" first="Agne S" last="Chompret">Agne S Chompret</name>
</author>
<author>
<name sortKey="Ghiorzo, Paola" sort="Ghiorzo, Paola" uniqKey="Ghiorzo P" first="Paola" last="Ghiorzo">Paola Ghiorzo</name>
</author>
<author>
<name sortKey="Gruis, Nelleke" sort="Gruis, Nelleke" uniqKey="Gruis N" first="Nelleke" last="Gruis">Nelleke Gruis</name>
</author>
<author>
<name sortKey="Hansson, Johan" sort="Hansson, Johan" uniqKey="Hansson J" first="Johan" last="Hansson">Johan Hansson</name>
</author>
<author>
<name sortKey="Harland, Mark" sort="Harland, Mark" uniqKey="Harland M" first="Mark" last="Harland">Mark Harland</name>
</author>
<author>
<name sortKey="Hayward, Nicholas" sort="Hayward, Nicholas" uniqKey="Hayward N" first="Nicholas" last="Hayward">Nicholas Hayward</name>
</author>
<author>
<name sortKey="Holland, Elizabeth A" sort="Holland, Elizabeth A" uniqKey="Holland E" first="Elizabeth A." last="Holland">Elizabeth A. Holland</name>
</author>
<author>
<name sortKey="Mann, Graham J" sort="Mann, Graham J" uniqKey="Mann G" first="Graham J." last="Mann">Graham J. Mann</name>
</author>
<author>
<name sortKey="Mantelli, Michela" sort="Mantelli, Michela" uniqKey="Mantelli M" first="Michela" last="Mantelli">Michela Mantelli</name>
</author>
<author>
<name sortKey="Nancarrow, Derek" sort="Nancarrow, Derek" uniqKey="Nancarrow D" first="Derek" last="Nancarrow">Derek Nancarrow</name>
</author>
<author>
<name sortKey="Platz, Anton" sort="Platz, Anton" uniqKey="Platz A" first="Anton" last="Platz">Anton Platz</name>
</author>
<author>
<name sortKey="Tucker, Margaret A" sort="Tucker, Margaret A" uniqKey="Tucker M" first="Margaret A." last="Tucker">Margaret A. Tucker</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:2DFFC5703ECEE7285C33FFD09BA864A9429998AF</idno>
<date when="2002" year="2002">2002</date>
<idno type="doi">10.1093/jnci/94.12.894</idno>
<idno type="url">https://api.istex.fr/document/2DFFC5703ECEE7285C33FFD09BA864A9429998AF/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000891</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000891</idno>
<idno type="wicri:Area/Istex/Curation">000891</idno>
<idno type="wicri:Area/Istex/Checkpoint">001C46</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001C46</idno>
<idno type="wicri:doubleKey">0027-8874:2002:Bishop D:geographical:variation:in</idno>
<idno type="wicri:Area/Main/Merge">00C207</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:03-0047983</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">005498</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000C28</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005409</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005409</idno>
<idno type="wicri:doubleKey">0027-8874:2002:Bishop D:geographical:variation:in</idno>
<idno type="wicri:Area/Main/Merge">00C530</idno>
<idno type="wicri:Area/Main/Curation">00B416</idno>
<idno type="wicri:Area/Main/Exploration">00B416</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma</title>
<author>
<name sortKey="Bishop, D Timothy" sort="Bishop, D Timothy" uniqKey="Bishop D" first="D. Timothy" last="Bishop">D. Timothy Bishop</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Demenais, Florence" sort="Demenais, Florence" uniqKey="Demenais F" first="Florence" last="Demenais">Florence Demenais</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Goldstein, Alisa M" sort="Goldstein, Alisa M" uniqKey="Goldstein A" first="Alisa M." last="Goldstein">Alisa M. Goldstein</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bergman, Wilma" sort="Bergman, Wilma" uniqKey="Bergman W" first="Wilma" last="Bergman">Wilma Bergman</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bishop, Julia Newton" sort="Bishop, Julia Newton" uniqKey="Bishop J" first="Julia Newton" last="Bishop">Julia Newton Bishop</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Paillerets, Brigitte Bressac De" sort="Paillerets, Brigitte Bressac De" uniqKey="Paillerets B" first="Brigitte Bressac-De" last="Paillerets">Brigitte Bressac-De Paillerets</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Chompret, Agne S" sort="Chompret, Agne S" uniqKey="Chompret A" first="Agne S" last="Chompret">Agne S Chompret</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ghiorzo, Paola" sort="Ghiorzo, Paola" uniqKey="Ghiorzo P" first="Paola" last="Ghiorzo">Paola Ghiorzo</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Gruis, Nelleke" sort="Gruis, Nelleke" uniqKey="Gruis N" first="Nelleke" last="Gruis">Nelleke Gruis</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hansson, Johan" sort="Hansson, Johan" uniqKey="Hansson J" first="Johan" last="Hansson">Johan Hansson</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Harland, Mark" sort="Harland, Mark" uniqKey="Harland M" first="Mark" last="Harland">Mark Harland</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hayward, Nicholas" sort="Hayward, Nicholas" uniqKey="Hayward N" first="Nicholas" last="Hayward">Nicholas Hayward</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Holland, Elizabeth A" sort="Holland, Elizabeth A" uniqKey="Holland E" first="Elizabeth A." last="Holland">Elizabeth A. Holland</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mann, Graham J" sort="Mann, Graham J" uniqKey="Mann G" first="Graham J." last="Mann">Graham J. Mann</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Mantelli, Michela" sort="Mantelli, Michela" uniqKey="Mantelli M" first="Michela" last="Mantelli">Michela Mantelli</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nancarrow, Derek" sort="Nancarrow, Derek" uniqKey="Nancarrow D" first="Derek" last="Nancarrow">Derek Nancarrow</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Platz, Anton" sort="Platz, Anton" uniqKey="Platz A" first="Anton" last="Platz">Anton Platz</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tucker, Margaret A" sort="Tucker, Margaret A" uniqKey="Tucker M" first="Margaret A." last="Tucker">Margaret A. Tucker</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Affiliations of authors: D. T. Bishop, J. Newton Bishop, M. Harland, Genetic Epidemiology Division, Cancer Research UK Clinical Centre, Leeds, U.K.; F. Demenais, Institut National de la Santé et de la Recherche Médicale EMI 00–06, Evry, France; A. M. Goldstein, M. A. Tucker, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD; W. Bergman, N. Gruis, Department of Dermatology and Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands; B. Bressac-de Paillerets, A. Chompret, Institut Gustave Rousy, Villejuif, France; P. Ghiorzo, M. Mantelli, Department of Oncology, Biology, and Genetics, University of Genova, Genova, Italy; J. Hansson, A. Platz, Department of Oncology–Pathology, Karolinska Hospital, Stockholm, Sweden; N. Hayward, D. Nancarrow, Queensland Cancer Fund Research Unit, Brisbane, Australia; E. A. Holland, G. J. Mann, Westmead Institute for Cancer Research, Sydney</wicri:regionArea>
<placeName>
<settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of the National Cancer Institute</title>
<title level="j" type="abbrev">JNCI J Natl Cancer Inst</title>
<idno type="ISSN">0027-8874</idno>
<idno type="eISSN">1460-2105</idno>
<imprint>
<publisher>Oxford University Press</publisher>
<date type="published" when="2002-06-19">2002-06-19</date>
<biblScope unit="volume">94</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="894">894</biblScope>
<biblScope unit="page" to="903">903</biblScope>
</imprint>
<idno type="ISSN">0027-8874</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0027-8874</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Ascertainment</term>
<term>Australia</term>
<term>Baseline</term>
<term>Bergman</term>
<term>Blood sample</term>
<term>CDKN2 gene</term>
<term>Cancer research</term>
<term>Case patients</term>
<term>Cdk4</term>
<term>Cdkn2a</term>
<term>Cdkn2a mutation</term>
<term>Cdkn2a mutation penetrance</term>
<term>Cdkn2a mutations</term>
<term>Cdkn2a penetrance</term>
<term>Chromosome</term>
<term>Cohort</term>
<term>Consortium</term>
<term>Covariates</term>
<term>Cutaneous</term>
<term>Cutaneous melanoma</term>
<term>Demenais</term>
<term>Dermatologist</term>
<term>Epidemiology</term>
<term>Europe</term>
<term>European countries</term>
<term>Exon</term>
<term>Familial melanoma</term>
<term>Family history</term>
<term>Family members</term>
<term>Gene penetrance</term>
<term>Genet</term>
<term>Genetics</term>
<term>Genotype</term>
<term>Genova</term>
<term>Geographic location</term>
<term>Geographical variation</term>
<term>Germline</term>
<term>Germline mutations</term>
<term>Goldstein</term>
<term>Hazard function</term>
<term>Human</term>
<term>Incidence</term>
<term>Incidence rates</term>
<term>June</term>
<term>Leiden</term>
<term>Leiden university</term>
<term>Melanoma</term>
<term>Melanoma families</term>
<term>Melanoma genetics consortium</term>
<term>Missense</term>
<term>More detail</term>
<term>Multiple cases</term>
<term>Mutation</term>
<term>Mutation carriers</term>
<term>National cancer institute</term>
<term>Natl</term>
<term>Natl cancer inst</term>
<term>Nevus</term>
<term>Newton bishop</term>
<term>Penetrance</term>
<term>Penetrance estimates</term>
<term>Penetrance function</term>
<term>Queensland</term>
<term>Skin</term>
<term>Tumor suppressor gene</term>
<term>Unaffected</term>
<term>Unaffected family members</term>
<term>Unaffected relatives</term>
<term>United States</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Australie</term>
<term>Epidémiologie</term>
<term>Etats Unis</term>
<term>Europe</term>
<term>Gène CDKN2</term>
<term>Gène suppresseur tumeur</term>
<term>Homme</term>
<term>Incidence</term>
<term>Mélanome</term>
<term>Peau</term>
<term>Pénétrance génique</term>
<term>Variation géographique</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Ascertainment</term>
<term>Baseline</term>
<term>Bergman</term>
<term>Blood sample</term>
<term>Cancer research</term>
<term>Case patients</term>
<term>Cdk4</term>
<term>Cdkn2a</term>
<term>Cdkn2a mutation</term>
<term>Cdkn2a mutation penetrance</term>
<term>Cdkn2a mutations</term>
<term>Cdkn2a penetrance</term>
<term>Chromosome</term>
<term>Cohort</term>
<term>Consortium</term>
<term>Covariates</term>
<term>Cutaneous</term>
<term>Cutaneous melanoma</term>
<term>Demenais</term>
<term>Dermatologist</term>
<term>Epidemiology</term>
<term>European countries</term>
<term>Exon</term>
<term>Familial melanoma</term>
<term>Family history</term>
<term>Family members</term>
<term>Genet</term>
<term>Genetics</term>
<term>Genotype</term>
<term>Genova</term>
<term>Geographic location</term>
<term>Germline</term>
<term>Germline mutations</term>
<term>Goldstein</term>
<term>Hazard function</term>
<term>Incidence rates</term>
<term>June</term>
<term>Leiden</term>
<term>Leiden university</term>
<term>Melanoma</term>
<term>Melanoma families</term>
<term>Melanoma genetics consortium</term>
<term>Missense</term>
<term>More detail</term>
<term>Multiple cases</term>
<term>Mutation</term>
<term>Mutation carriers</term>
<term>National cancer institute</term>
<term>Natl</term>
<term>Natl cancer inst</term>
<term>Nevus</term>
<term>Newton bishop</term>
<term>Penetrance</term>
<term>Penetrance estimates</term>
<term>Penetrance function</term>
<term>Queensland</term>
<term>Unaffected</term>
<term>Unaffected family members</term>
<term>Unaffected relatives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Australie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Consortium</term>
<term>Homme</term>
<term>épidémiologie</term>
<term>Génétique</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background: Germline mutations in the CDKN2A gene, which encodes two proteins (p16INK4A and p14ARF), are the most common cause of inherited susceptibility to melanoma. We examined the penetrance of such mutations using data from eight groups from Europe, Australia and the United States that are part of The Melanoma Genetics Consortium. Methods: We analyzed 80 families with documented CDKN2A mutations and multiple cases of cutaneous melanoma. We modeled penetrance for melanoma using a logistic regression model incorporating survival analysis. Hypothesis testing was based on likelihood ratio tests. Covariates included gender, alterations in p14ARF protein, and population melanoma incidence rates. All statistical tests were two-sided. Results: The 80 analyzed families contained 402 melanoma patients, 320 of whom were tested for mutations and 291 were mutation carriers. We also tested 713 unaffected family members for mutations and 194 were carriers. Overall, CDKN2A mutation penetrance was estimated to be 0.30 (95% confidence interval (CI) = 0.12 to 0.62) by age 50 years and 0.67 (95% CI = 0.31 to 0.96) by age 80 years. Penetrance was not statistically significantly modified by gender or by whether the CDKN2A mutation altered p14ARF protein. However, there was a statistically significant effect of residing in a location with a high population incidence rate of melanoma (P = .003). By age 50 years CDKN2A mutation penetrance reached 0.13 in Europe, 0.50 in the United States, and 0.32 in Australia; by age 80 years it was 0.58 in Europe, 0.76 in the United States, and 0.91 in Australia. Conclusions: This study, which gives the most informed estimates of CDKN2A mutation penetrance available, indicates that the penetrance varies with melanoma population incidence rates. Thus, the same factors that affect population incidence of melanoma may also mediate CDKN2A penetrance.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
</country>
<region>
<li>Nouvelle-Galles du Sud</li>
</region>
<settlement>
<li>Sydney</li>
</settlement>
</list>
<tree>
<country name="Australie">
<region name="Nouvelle-Galles du Sud">
<name sortKey="Bishop, D Timothy" sort="Bishop, D Timothy" uniqKey="Bishop D" first="D. Timothy" last="Bishop">D. Timothy Bishop</name>
</region>
<name sortKey="Bergman, Wilma" sort="Bergman, Wilma" uniqKey="Bergman W" first="Wilma" last="Bergman">Wilma Bergman</name>
<name sortKey="Bishop, Julia Newton" sort="Bishop, Julia Newton" uniqKey="Bishop J" first="Julia Newton" last="Bishop">Julia Newton Bishop</name>
<name sortKey="Chompret, Agne S" sort="Chompret, Agne S" uniqKey="Chompret A" first="Agne S" last="Chompret">Agne S Chompret</name>
<name sortKey="Demenais, Florence" sort="Demenais, Florence" uniqKey="Demenais F" first="Florence" last="Demenais">Florence Demenais</name>
<name sortKey="Ghiorzo, Paola" sort="Ghiorzo, Paola" uniqKey="Ghiorzo P" first="Paola" last="Ghiorzo">Paola Ghiorzo</name>
<name sortKey="Goldstein, Alisa M" sort="Goldstein, Alisa M" uniqKey="Goldstein A" first="Alisa M." last="Goldstein">Alisa M. Goldstein</name>
<name sortKey="Gruis, Nelleke" sort="Gruis, Nelleke" uniqKey="Gruis N" first="Nelleke" last="Gruis">Nelleke Gruis</name>
<name sortKey="Hansson, Johan" sort="Hansson, Johan" uniqKey="Hansson J" first="Johan" last="Hansson">Johan Hansson</name>
<name sortKey="Harland, Mark" sort="Harland, Mark" uniqKey="Harland M" first="Mark" last="Harland">Mark Harland</name>
<name sortKey="Hayward, Nicholas" sort="Hayward, Nicholas" uniqKey="Hayward N" first="Nicholas" last="Hayward">Nicholas Hayward</name>
<name sortKey="Holland, Elizabeth A" sort="Holland, Elizabeth A" uniqKey="Holland E" first="Elizabeth A." last="Holland">Elizabeth A. Holland</name>
<name sortKey="Mann, Graham J" sort="Mann, Graham J" uniqKey="Mann G" first="Graham J." last="Mann">Graham J. Mann</name>
<name sortKey="Mantelli, Michela" sort="Mantelli, Michela" uniqKey="Mantelli M" first="Michela" last="Mantelli">Michela Mantelli</name>
<name sortKey="Nancarrow, Derek" sort="Nancarrow, Derek" uniqKey="Nancarrow D" first="Derek" last="Nancarrow">Derek Nancarrow</name>
<name sortKey="Paillerets, Brigitte Bressac De" sort="Paillerets, Brigitte Bressac De" uniqKey="Paillerets B" first="Brigitte Bressac-De" last="Paillerets">Brigitte Bressac-De Paillerets</name>
<name sortKey="Platz, Anton" sort="Platz, Anton" uniqKey="Platz A" first="Anton" last="Platz">Anton Platz</name>
<name sortKey="Tucker, Margaret A" sort="Tucker, Margaret A" uniqKey="Tucker M" first="Margaret A." last="Tucker">Margaret A. Tucker</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B416 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B416 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:2DFFC5703ECEE7285C33FFD09BA864A9429998AF
   |texte=   Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024